作者
Andrea C Haynes, Helen Chapman, Colleen Taylor, Gary BT Moore, Michael A Cawthorne, Mohammad Tadayyon, John C Clapham, Jonathan RS Arch
发表日期
2002/3/15
期刊
Regulatory peptides
卷号
104
期号
1-3
页码范围
153-159
出版商
Elsevier
简介
A single dose of the orexin-1 (OX1) receptor antagonist 1-(2-methylbenzoxazol-6-yl)-3-[1,5] naphthyridin-4-yl urea hydrochloride (SB-334867-A) reduces orexin-A-induced feeding and natural feeding in Sprague Dawley rats. In this study, the anti-obesity effects of SB-334867-A were determined in genetically obese (ob/ob) mice dosed with SB-334867-A (30 mg/kg, i.p.) once daily for 7 days, and then twice daily for a further 7 days. SB-334867-A reduced cumulative food intake and body weight gain over 14 days. Total fat mass gain, determined by Dual Emission X-ray Absorptiometry, was reduced, while gain in fat-free mass was unchanged. Fasting (5 h) blood glucose was also reduced at the end of the study, with a trend to reduced plasma insulin. Interscapular brown adipose tissue (BAT) weight was reduced, the tissue was noticeably darker in colour and quantitative PCR (TaqMan) analysis of this tissue showed a …
引用总数
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220233681481278915129911711887866